全文获取类型
收费全文 | 258662篇 |
免费 | 19584篇 |
国内免费 | 1142篇 |
专业分类
耳鼻咽喉 | 2935篇 |
儿科学 | 6527篇 |
妇产科学 | 4617篇 |
基础医学 | 33090篇 |
口腔科学 | 10810篇 |
临床医学 | 25565篇 |
内科学 | 53950篇 |
皮肤病学 | 3455篇 |
神经病学 | 24387篇 |
特种医学 | 8433篇 |
外国民族医学 | 11篇 |
外科学 | 38987篇 |
综合类 | 3483篇 |
一般理论 | 318篇 |
预防医学 | 21548篇 |
眼科学 | 6566篇 |
药学 | 17008篇 |
6篇 | |
中国医学 | 361篇 |
肿瘤学 | 17331篇 |
出版年
2023年 | 1674篇 |
2022年 | 2420篇 |
2021年 | 5469篇 |
2020年 | 3366篇 |
2019年 | 5330篇 |
2018年 | 6172篇 |
2017年 | 4783篇 |
2016年 | 5311篇 |
2015年 | 6264篇 |
2014年 | 9054篇 |
2013年 | 12227篇 |
2012年 | 18260篇 |
2011年 | 19158篇 |
2010年 | 10920篇 |
2009年 | 9951篇 |
2008年 | 16856篇 |
2007年 | 17661篇 |
2006年 | 17523篇 |
2005年 | 17453篇 |
2004年 | 16346篇 |
2003年 | 15255篇 |
2002年 | 14243篇 |
2001年 | 2307篇 |
2000年 | 1795篇 |
1999年 | 2512篇 |
1998年 | 3293篇 |
1997年 | 2760篇 |
1996年 | 2368篇 |
1995年 | 2257篇 |
1994年 | 1907篇 |
1993年 | 1691篇 |
1992年 | 1419篇 |
1991年 | 1258篇 |
1990年 | 1112篇 |
1989年 | 1051篇 |
1988年 | 1061篇 |
1987年 | 1037篇 |
1986年 | 1000篇 |
1985年 | 1038篇 |
1984年 | 1290篇 |
1983年 | 1188篇 |
1982年 | 1420篇 |
1981年 | 1352篇 |
1980年 | 1162篇 |
1979年 | 716篇 |
1978年 | 767篇 |
1977年 | 650篇 |
1976年 | 597篇 |
1975年 | 486篇 |
1974年 | 491篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Martin C. Robson MD ; Diane M. Cooper PhD RN ; Rummana Aslam MD ; Lisa J. Gould MD PhD ; Keith G. Harding MBChB MRCGP FRCS ; David J. Margolis MD MSCE PhD ; Diane E. Ochs RN ; Thomas E. Serena MD ; Robert J. Snyder DPM ; David L. Steed MD ; David R. Thomas MD ; Laurel Wiersema-Bryant RN BC ANP 《Wound repair and regeneration》2008,16(2):147-150
992.
Avian influenza (AI) and Newcastle disease (ND) viruses are heat labile viruses, but exact parameters for heat inactivation at egg pasteurization temperatures have not been established. In this study we artificially infected four egg products with two AI (one low [LP] and one high pathogenicity [HP]) and three ND (two low and one highly virulent) viruses, and determined inactivation curves at 55, 57, 59, 61 and 63 degrees C. Based on D(t) values, the time to inactivation of the viruses was dependent on virus strain and egg product, and was directly related to virus titre, but inversely related to temperature. For all temperatures, the five viruses had the most rapid and complete inactivation in 10% salt yolk, while the most resistant to inactivation was HPAI virus in dried egg white. This study demonstrated that the LPAI and all ND viruses were inactivated in all egg products when treated using industry standard pasteurization protocols. By contrast, the HPAI virus was inactivated in liquid egg products but not in dried egg whites when using the low-temperature industry pasteurization protocol. 相似文献
993.
The authors report a 50-year-old man with progressive left hemispheric atrophy, cognitive decline, infrequent seizures, and spells suggestive of complicated migraine. They discuss the association between migraine and cerebral hemiatrophy and suggest that the spectrum of acquired cerebral hemiatrophy may be broader than what has been commonly recognized. 相似文献
994.
995.
996.
Malignant peripheral nerve sheath tumors (MPNST) are defined as any tumor arising from a peripheral nerve or showing nerve
sheath differentiation. The majority of these tumors arise on the trunk, extremities, or head and neck region. The literature
to date has fewer than 14 cases of MPNST arising in the gastrointestinal tract, and only two cases were ever reported in the
small intestine, one of which was a recurrent disease. In this paper, we report the first US case of an MPNST arising in the
small intestine and presenting as intussusception. 相似文献
997.
BACKGROUND: IgE-mediated carboplatin hypersensitivity reactions occur in up to 30% of patients receiving this agent for chemotherapy of solid tumors, thus limiting therapeutic options. OBJECTIVE: To describe our experience with intravenous carboplatin desensitization regimens, which culminated in a standardized, successful protocol for safe administration. METHODS: Eight consecutive patients with ovarian cancer who had experienced severe anaphylactic reactions to carboplatin were referred to our hospital. Intradermal skin testing was performed by raising a 3-mm bleb by injection of undiluted carboplatin at 10 mg/mL, and the wheal size was read at 20 minutes. The outcomes of the various desensitization regimens were documented prospectively, and the experience gained was used to develop a standardized protocol for administration. RESULTS: All patients had positive intradermal skin test results. The first 3 patients were treated with short (90 minutes to 6 hours) desensitization protocols, and all protocols failed on the first or second infusions. These 3 and a subsequent 5 patients were given intravenous carboplatin according to a protocol of gradual dose escalation over a 4-log dose range given during a 4-day period, with subsequent 3-weekly infusions given more rapidly by omitting the most dilute log dose on each occasion. All patients tolerated the longer infusion protocol without event, and all but 1 patient experienced appropriate tumor marker response. CONCLUSIONS: Short carboplatin desensitization protocols (less than 6 hours) have an unacceptable failure rate in patients with carboplatin allergy, but longer infusion times (days) are well tolerated without recurrence of the allergic reaction and with good tumor response. In cases where carboplatin is the optimal therapeutic agent, clinicians should not be deterred by an anaphylactic reaction to it or by failure of shorter desensitization regimens. 相似文献
998.
Growth hormone effects on hypertrophic scar formation: a randomized controlled trial of 62 burned children 总被引:3,自引:0,他引:3
Gisele V. de Oliveira MD ; Arthur P. Sanford MD ; Kevin D. Murphy MD ; Hermes M. de Oliveira MD ; Judy P. Wilkins RGN ; Xiaowu Wu MD ; Hal K. Hawkins MD PhD ; Gregory Kitten PhD ; David L. Chinkes PhD ; Robert E. Barrow PhD ; David N. Herndon MD 《Wound repair and regeneration》2004,12(4):404-411
The hypercatabolism after massive pediatric burns has been effectively treated with recombinant human growth hormone, an anabolic agent that stimulates protein synthesis and abrogates growth arrest. While experimental studies have shown increased potential for fibrosis induced by growth hormone therapy, adverse effects on human scars have not been investigated. Our aim was to evaluate hypertrophic scar formation in 62 patients randomized to receive injections of 0.05 mg/kg/day of recombinant human growth hormone or placebo, from discharge until 1 year after burn. Scar scales were used to evaluate scar-severity at discharge, 6, 9, 12, and 18-24 months after burn, by three observers blinded to treatment. Computer-assisted planimetry allowed quantification of percentage of hypertrophic scar formation. Types I and III collagens were localized and quantified in scars and normal skin of patients from both groups, using immunohistochemistry with confocal laser microscopy analysis. Insulin-like growth factor-1 blood levels helped assess compliance. Statistical analysis showed that scar hypertrophy significantly increased from 6 to 12 months after injury in both groups, while decreasing at 18-24 months postburn. Types I and III collagens were statistically increased in the reticular layer of scars from both groups when compared to paired normal skin. Insulin-like growth factor-1 was significantly increased in the recombinant human growth factor-treated group. No differences were seen when recombinant human growth factor and control groups were compared using the scar scales, planimetry, or immunohistochemistry. We concluded that recombinant human growth hormone therapy did not adversely affect scar formation and should not contraindicate the administration of recombinant human growth hormone as a therapeutic approach to severely burned children. 相似文献
999.
1000.
Anette M.C. Fransson DDS A
ke Tegelberg DDS PhD Anders Johansson DDS PhD Bengt Wenneberg DDS PhD 《American journal of orthodontics and dentofacial orthopedics》2004,126(6):687-693
The aim was to identify the incidence and types of possible adverse events in the masticatory system after treatment with a mandibular protruding device (MPD) during a 2-year period in patients with obstructive sleep apnea (OSA) or snoring. The subjects comprised 65 middle-aged patients (44 OSA patients, 21 snorers). A clinical examination and a questionnaire concerning signs and symptoms from the masticatory system were performed before, after 6 months, and after 2 years of MPD use. The frequencies of registered signs from the masticatory system, such as muscle and joint tenderness, palpation, and pain during mandibular movement, decreased significantly between baseline and the 2-year follow-up. There were significant changes in the mandibular range of protrusion (+0.7 mm, P < .001), overjet (-0.5 mm, P < .001), and overbite (-0.6 mm, P < .001) compared with the initial examination. Nine patients developed a lateral open bite during treatment, and 2 of them experienced subjective symptoms related to the altered occlusion but still used the MPD every night. No patient reported pain on opening the mouth wide or during jaw movements. Two reported tiredness on jaw function. The reported frequency of headaches was also significantly reduced (P < .01). The high compliance rate in MPD use showed that the therapy is well tolerated, but there is a risk of minor alterations in the occlusion during MPD treatment. 相似文献